Transdermal therapeutic systems (TTS)
Niedner, R.
Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 39(12): 761-766
1988
ISSN/ISBN: 0017-8470 PMID: 2976752 Document Number: 321665
The technique, pharmacokinetics, and advantages and disadvantages of transdermal drug delivery systems (TDS) are discussed. Special emphasis is laid on the dermatological problems arising during use of the TDS, such as irritation, sensitization, and the effects of occlusion, dermatoses, skin microflora and epidermal metabolism.
Document emailed within 1 workday
Related Documents
Mutschler, E.; Langguth, P. 1987: Transdermal therapeutic systems Fortschritte der Medizin 105(29): 571-574Pflegel, P.; Dittgen, M. 1987: Drugs and the body (VI)--Transdermal therapeutic systems Die Pharmazie 42(12): 799-809
Csóka, G.; Pásztor, E.; Marton, S.; Zelkó, R.án.; Antal, I.; Klebovich, I. 2007: Formulation of thermoresponsive transdermal therapeutic systems using cellulose derivatives Acta Pharmaceutica Hungarica 77(2): 102-107
Rehula, M. 1992: The effect of additives on the availability of atropine in transdermal therapeutic systems Ceskoslovenska Farmacie 40(8-10): 230-233
Kramar, M.; Giersch, K.H.; Schneider, H.T. 1987: Transdermal therapy of stable angina pectoris. Comparison of 2 different transdermal systems Fortschritte der Medizin 105(17): 340-342
Harrison, L.I.; Riedel, D.J. 1991: Transdermal nitroglycerin systems: methods for comparison Clinical Therapeutics 13(3): 361-367
Aiache, J.M. 1997: Transdermal therapeutic methods Annales de Cardiologie et d'Angeiologie 46(7): 441-449
Junginger, H.E. 1992: Formulation aspects on dermatological preparations and transdermal drug delivery systems Acta Pharmaceutica Nordica 4(2): 117
Sariev, A.K.; Zherdev, V.P.; Sologova, S.S.; Litvin, A.A.; Rodionov, A.P.; Kolyvanov, G.B.; Vasil'ev, A.E. 1999: Cytisine pharmacokinetics when used in a transdermal therapeutic system in rabbits Eksperimental'naia i Klinicheskaia Farmakologiia 62(6): 59-61
Monti, D.; Galli-Angeli, D.; Giannaccini, B.; Saettone, M.F. 1993: Setup and evaluation "in vitro" of a transdermal therapeutic system Bollettino Chimico Farmaceutico 132(2): 58-59
Khurmi, N.S.; O'Hara, M.J.; Bowles, M.J.; Whittington, J.R.; Lahiri, A.; Raftery, E.B. 1986: Transmucosal and transdermal nitroglycerin delivery systems for prevention of chronic stable angina pectoris British Journal of Clinical Practice 40(5): 187-191
Pfister, W.R.; Hsieh, D.S. 1990: Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations Medical Device Technology 1(6): 28-33
Litvin, A.A. 2004: Experimental pharmacokinetics of phenazepam during transdermal administration of the therapeutic phenaperkuten system Eksperimental'naia i Klinicheskaia Farmakologiia 67(2): 59-62
Gruber, D.; Skřivánek, A.; Serrani, M.; Lanius, V.; Merz, M. 2015: A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study Contraception 91(2): 105-112
Alfaya, T.; Mur Gimeno, P.; Iglesias, A.M.; Ventura, P.ón. 2011: Allergic contact dermatitis caused by an ethinylestradiol-norelgestromin transdermal therapeutic system Contact Dermatitis 64(4): 242-244
Solenkova, A.V.; Imaev, A.A.; Bondarenko, A.A.; Lubnin, A.Iu. 2011: Analysis of efficacy and safety of preventive analgesia with transdermal therapeutic system Duragesic Matrix in spine surgery Anesteziologiia i Reanimatologiia 2011(4): 32-37
Foldvari, M.; Baca-Estrada, M.E.; He, Z.; Hu, J.; Attah-Poku, S.; King, M. 1999: Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha Biotechnology and Applied Biochemistry 30(2): 129-137
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Lorvidhaya, V.; Katanyoo, K.; Srisomboon, J.; Suprapaphorn, P.; Cheewakriangkrai, C. 2004: Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain Journal of the Medical Association of Thailand 87(3): 319-325